PMEF
KLRS

Point72 Middle East FZE’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Point72 Middle East FZE’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-354
Closed -$27.7K – 1481
2023
Q2 		$27.7K Buy
354
+281
+385% +$22K ﹤0.01% 817
2023
Q1 		$6.63K Sell
73
-144
-66% -$13.1K ﹤0.01% 957
2022
Q4 		$25.6K Buy
+217
New +$25.6K ﹤0.01% 1046